Please ensure Javascript is enabled for purposes of website accessibility

Wall Street’s Best Investments 831

The markets are certainly keeping us on our toes! I really didn’t know what to expect when I began calculating the returns for this Mid-Year Top Picks issue. We’ve had so much volatility; a big disruption in March, as coronavirus took hold; and many sectors that just haven’t bounced back.

So, you can imagine my relief and joy when I totaled up our contributors’ gains for the first six months of the year!

Despite the ongoing devastation of COVID-19, our contributors have broken all of our records, averaging a gain of 16.41%, while the Dow fell 8.6%, the S&P 500 is down 1.2% and only the Nasdaq is in positive territory, with gains of 18.3%.

Even better, our Top 5 picks averaged 221.48%!

Wall Street’s Best Investments 831

[premium_html_toc post_id="210341"]

The markets are certainly keeping us on our toes! I really didn’t know what to expect when I began calculating the returns for this Mid-Year Top Picks issue. We’ve had so much volatility; a big disruption in March, as coronavirus took hold; and many sectors that just haven’t bounced back.

So, you can imagine my relief and joy when I totaled up our contributors’ gains for the first six months of the year!

Despite the ongoing devastation of COVID-19, our contributors have broken all of our records, averaging a gain of 16.41%, while the Dow fell 8.6%, the S&P 500 is down 1.2% and only the Nasdaq is in positive territory, with gains of 18.3%.

Even better, our Top 5 picks averaged 221.48%!

Our top 5 winners were:

  • Joseph Cotton of Cotton’s Technically Speaking, with a gain of 742.86% for his pick, Inovio Pharmaceuticals (INO)
  • Joseph Parnes of Shortex Market Letter, who chose Tesla (TSLA) for a 194.87% return
  • John Gardner, of Equity Research & Portfolio Evaluation, saw a 61.92% rise in his pick, The Trade Desk (TTD)
  • Tom Bishop of BI Research picked Anavex Life Sciences (AVXL), which rewarded him with a 55.96% return
  • Jeffrey Hirsch of Stock Trader’s Almanac chose Horizon Therapeutics (HZNP), for a gain of 51.80%.

Congratulations to our contributors and especially to our big winners!

Our contributors are still bullish on the markets, and so is the overall investment pro community, as you’ll see in our Advisor Sentiment Barometer.

In this month’s issue, we bring you an update on many of our 2020 Top Picks, along with several new non-Top Picks ideas.

In Top Picks-Growth, you’ll find updates in the electric auto, entertainment, and marijuana industries. In Top Picks-Financials, our contributors have updated a previous bank recommendation. And in Top Picks-Technology, you’ll see a company that our advisor sold.

We have quite a few updates for you in Top Picks-Healthcare, from the pharmaceutical, medical devices, and drugstore sectors. In Top Picks-Energy, our contributors have updated midstream, utility, and equipment companies.

Our Top Picks-Low Priced Stocks include two speculative ideas in the medical laboratory and a company who has tendrils in several businesses, including metals, media, and renewable energy. And in Top Picks-Funds & ETFs, we offer a gold exchange-traded fund for your review.

Moving on to our non-Top-Picks ideas, our Growth stocks include a ski resort operator, an online sports-betting company, an equipment rental business, a retail jeweler, a sports apparel maker, and a food producer.

In Growth & Income, you’ll find ideas from the insurance, business services, and clothing manufacturing. In Financials, we offer a bank and a private mortgage insurer. Our Healthcare ideas include two medical device companies.

Our technology recommendations include a fintech business and a payment processor. In Preferred Stocks & REITs, you’ll find a Preferred Stock issued by a telecom giant and a Real Estate Investment Trust that owns medical research and laboratory facilities.

Lastly, our Funds & ETFs offer two ideas in the emerging markets and gold sectors.

I hope you are weathering this pandemic and can enjoy the extra time with your families. I wish you the best of health and continued prosperity. Please don’t hesitate to email me with your feedback and questions. My address is nancy@cabotwealth.com.

To read the rest of this month’s issue, download the PDF.


The next Wall Street’s Best Investments issue will be published on August 27, 2020.

Cabot Wealth Network
Publishing independent investment advice since 1970.

CEO & Chief Investment Strategist: Timothy Lutts
President & Publisher: Ed Coburn
176 North Street, PO Box 2049, Salem, MA 01970 USA
800-326-8826 | support@cabotwealth.com | CabotWealth.com

Copyright © 2020. All rights reserved. Copying or electronic transmission of this information is a violation of copyright law. For the protection of our subscribers, copyright violations will result in immediate termination of all subscriptions without refund. No Conflicts: Cabot Wealth Network exists to serve you, our readers. We derive 100% of our revenue, or close to it, from selling subscriptions to its publications. Neither Cabot Wealth Network nor our employees are compensated in any way by the companies whose stocks we recommend or providers of associated financial services. Disclaimer: Sources of information are believed to be reliable but they are not guaranteed to be complete or error-free. Recommendations, opinions or suggestions are given with the understanding that subscribers acting on information assume all risks involved.